Free Trial
OTCMKTS:BAYRY

Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis

Bayer Aktiengesellschaft logo
$7.95 -0.13 (-1.61%)
As of 07/18/2025 03:59 PM Eastern

About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)

Key Stats

Today's Range
$7.95
$8.12
50-Day Range
$6.24
$8.12
52-Week Range
$4.79
$8.58
Volume
1.27 million shs
Average Volume
395,422 shs
Market Capitalization
$31.24 billion
P/E Ratio
N/A
Dividend Yield
0.25%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYRY Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

BAYRY Stock Analysis - Frequently Asked Questions

Bayer Aktiengesellschaft's stock was trading at $4.88 at the beginning of the year. Since then, BAYRY stock has increased by 62.9% and is now trading at $7.95.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) posted its earnings results on Tuesday, May, 13th. The company reported $0.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.02. The business earned $15.27 billion during the quarter, compared to analysts' expectations of $13.39 billion. Bayer Aktiengesellschaft had a negative net margin of 7.26% and a positive trailing twelve-month return on equity of 13.94%.

Bayer Aktiengesellschaft subsidiaries include Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and others.

Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Ex-Dividend for 5/12 Dividend
4/29/2025
Record date for 5/12 Dividend
4/30/2025
Dividend Payable
5/12/2025
Last Earnings
5/13/2025
Today
7/19/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
N/A
Current Symbol
OTCMKTS:BAYRY
CIK
1144145
Employees
92,815
Year Founded
1863

Profitability

EPS (Trailing Twelve Months)
($0.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
6.07
P/E Growth
N/A
Net Income
-$2.76 billion
Net Margins
-7.26%
Pretax Margin
-6.83%
Return on Equity
13.94%
Return on Assets
4.09%

Debt

Debt-to-Equity Ratio
1.07
Current Ratio
1.25
Quick Ratio
0.79

Sales & Book Value

Annual Sales
$50.44 billion
Price / Sales
0.62
Cash Flow
$3.73 per share
Price / Cash Flow
2.13
Book Value
$8.82 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
3,929,700,000
Free Float
N/A
Market Cap
$31.24 billion
Optionable
Not Optionable
Beta
0.86

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:BAYRY) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners